Rapid-Infusion Rituximab in Lymphoma Treatment: 2-Year Experience in a Single Institution
Journal of Oncology Practice, 05/25/2012
Clinical Article
Atay S et al. – A rapid infusion rituximab over 90minutes is well tolerated and safe when administered as the second and subsequent infusions in the course of therapy.



